2025 Rhinoplasty Course

Saturday, June 7, 2025, 7:30 AM - Sunday, June 8, 2025, 6:00 PM, UC Irvine Health Science Complex, Irvine, CA


AMA PRA Category 1 Credits™ (17.50 hours), Non-Physician Attendance (17.50 hours)

We will focus on basic rhinoplasty for the novice and will emphasize advanced topics. Special topics will include the use of fillers in rhinoplasty, adjunctive office-based maneuvers. Exhibitors will also be in attendance to demonstrate the latest in technology relevant to the practice of nasal surgery.

1. Improve participants' understanding of nasal anatomy and the functional aspects of rhinoplasty, including how to address airway obstruction and achieve optimal aesthetic outcomes.
2. Equip participants with the latest surgical techniques and maneuvers in rhinoplasty, focusing on both cosmetic refinements and functional improvements through step-by-step procedural insights.
3. Enhance participants’ ability to evaluate and manage complex rhinoplasty cases, including revision surgeries, while incorporating cultural, linguistic, and patient-centered care considerations for diverse patient populations.

https://secure.touchnet.net/C21570_ustores/web/product_detail.jsp?PRODUCTID=3392&SINGLESTORE=true

ADA Statement: In compliance with the Americans with Disabilities Act, we will make every reasonable effort to accommodate your request.  For any special requests, please contact the activity administrator before the meeting date.

The University of California, Irvine School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

University of California, Irvine School of Medicine Continuing Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.